Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Farlow

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
AJNR. American Journal of Neuroradiology|November 1, 1986
Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptomsM K Edwards, M R Farlow, J C Stevens
Life Sciences|January 1, 1997
The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cellsD K Lahiri, M R Farlow, K Sambamurti, et al.
Brain Research|January 31, 1992
Spectrum of amyloid beta-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP geneB Ghetti, J Murrell, M D Benson, et al.
International Journal of Clinical Practice|January 22, 2010
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trialsC H Sadowsky, M R Farlow, X Meng, et al.
Neurology|April 1, 1987
X-linked recessive inheritance of ataxia and adult-onset dementia: clinical features and preliminary linkage analysisM R Farlow, W DeMyer, S R Dlouhy, et al.
Archives of Neurology|March 1, 1989
Brain-stem auditory evoked potential abnormalities with unilateral brain-stem lesions demonstrated by magnetic resonance imagingO N Markand, M R Farlow, J C Stevens, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's diseaseM R Farlow, P M Doraiswamy, X Meng, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell culturesD K Lahiri, M R Farlow, J I Nurnberger, et al.
Neurology|June 1, 1996
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's diseaseL S Schneider, M R Farlow, V W Henderson, et al.
Annals of the New York Academy of Sciences|December 16, 1996
Apolipoprotein E genotype and gender influence response to tacrine therapyM R Farlow, D K Lahiri, J Poirier, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
AJNR. American Journal of Neuroradiology|November 1, 1986
Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptomsM K Edwards, M R Farlow, J C Stevens
Life Sciences|January 1, 1997
The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cellsD K Lahiri, M R Farlow, K Sambamurti, et al.
Brain Research|January 31, 1992
Spectrum of amyloid beta-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP geneB Ghetti, J Murrell, M D Benson, et al.
International Journal of Clinical Practice|January 22, 2010
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trialsC H Sadowsky, M R Farlow, X Meng, et al.
Neurology|April 1, 1987
X-linked recessive inheritance of ataxia and adult-onset dementia: clinical features and preliminary linkage analysisM R Farlow, W DeMyer, S R Dlouhy, et al.
Archives of Neurology|March 1, 1989
Brain-stem auditory evoked potential abnormalities with unilateral brain-stem lesions demonstrated by magnetic resonance imagingO N Markand, M R Farlow, J C Stevens, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's diseaseM R Farlow, P M Doraiswamy, X Meng, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell culturesD K Lahiri, M R Farlow, J I Nurnberger, et al.
Neurology|June 1, 1996
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's diseaseL S Schneider, M R Farlow, V W Henderson, et al.
Annals of the New York Academy of Sciences|December 16, 1996
Apolipoprotein E genotype and gender influence response to tacrine therapyM R Farlow, D K Lahiri, J Poirier, et al.
Pageof 12